Founded to revolutionize cancer diagnosis and treatment, Paige is a clinical AI company that leverages computational pathology to enhance cancer discovery and patient care. The company focuses on developing advanced software solutions for clinical applications, particularly in prostate and other cancers. Paige's core mission is to harness the power of AI to improve diagnostic accuracy and treatment outcomes, thereby transforming the landscape of cancer care. Their products include PRISM, a slide-level foundation model, and FullFocus®, a digital pathology viewer with Z-Stack viewing capabilities.
Paige has garnered significant attention and investment from notable figures in the healthcare and technology sectors. The company's innovative approach has led to several key achievements, including the introduction of foundational models that empower the next era of pathology and cancer treatment. By delivering cutting-edge AI technology, Paige has made a substantial impact on pharmaceutical and life science AI development, positioning itself as a leader in the field of computational pathology.
